CEO David Ricks got a 10% raise in 2024, as a surge in demand for weigh-loss drugs has propelled the pharma giant into the ...

Novo Nordisk stock tumbled Monday after its experimental weight-loss drug failed to top its rival from Eli Lilly in a Phase 3 study.

As earnings season begins, filings to the SEC point to uncertainty from the current administration as potential trouble for ...

The commerce secretary said any economic downturn would be because of Biden-era policies, arguing that Trump’s tariffs are spurring economic growth in the U.S.

In a video, Martin could be seen holding a press briefing when the US President said that he was distracted by Vance’s ...

FN Media Group News Commentary - A report from Fortune Business Insights said that the global artificial intelligence in healthcare market size is projected to grow from USD 27.69 billion in 2024 to ...

The Taoiseach Micheál Martin has been accused by Opposition parties of “plámásing” the US president while also drawing ...

Top high school girls and boys basketball players in the area were honored by the Mid-State League-Buckeye and Cardinal ...

Tennessee high school baseball, softball and boys soccer games began last week. Here are the top performers from the ...

"Billionaire" and "successful hedge fund manager" are titles that carry significant weight on Wall Street. These and others ...

Eli Lilly (LLY) believes its experimental weight-loss pill could make GLP-1 treatments more accessible worldwide.

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.